Physician profile
Brandon Mecham
NPI 1922395821
$10,241.24
in general payments reported to CMS, 2019-2025
24 companies · $1,417 in 2025
The $1,417 reported for 2025 was more than what 76% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $880 · 2020: $1,416 · 2021: $1,582 · 2022: $2,433 · 2023: $1,233 · 2024: $1,280 · 2025: $1,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,812 · Education: $601 · Travel and Lodging: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,811.86 |
| Education | $601.03 |
| Travel and Lodging | $516.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,226.03 | 2020-2025 | Prostep Mica, Prostep, Citrefix |
| Integra Lifesciences Corporation | $2,533.54 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $1,440.25 | 2019-2025 | Taylor Spatial Frame, Healicoil, Vlp Foot |
| Kci USA, INC. | $615.34 | 2019 | |
| Horizon Therapeutics Plc | $222.30 | 2021-2022 | |
| Wright Medical Technology, INC. | $193.95 | 2019-2020 | |
| Bioventus LLC | $155.87 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $147.00 | 2020-2024 | Orthovisc, Monovisc |
| Merck Sharp & Dohme LLC | $97.45 | 2019 | |
| Pylant Medical | $83.34 | 2020-2025 | |
| Paratek Pharmaceuticals, INC. | $80.20 | 2021-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $76.92 | 2025 | |
| In2bones USA, LLC | $60.55 | 2020 | |
| Orthofix Medical, INC. | $43.14 | 2024-2025 | Physio-Stim |
| Medtronic, INC. | $39.07 | 2024-2025 | Intellis Adaptivestim |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $36.67 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $34.40 | 2023 | Seglentis |
| Bone Support INC. | $32.07 | 2025 | Cerament G, Ceramentbone Void Filler |
| Nabriva Therapeutics, Plc | $28.48 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $26.20 | 2024 | |
| Becton, Dickinson and Company | $22.02 | 2022 | |
| Amgen INC. | $17.56 | 2025 | Krystexxa |
| Axogen | $14.71 | 2025 | |
| Fidia Pharma USA INC. | $14.18 | 2023 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Mecham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.